LY 294002 for PI3 Kinase Inhibition In Vitro

Toronto General Hospital Research Institute
University Health Network
Postdoctoral Researcher

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review

Company:

Cell Signaling Technology

Product Name:

LY294002

Catalog Number:

#9901

LY294002 is a highly selective inhibitor of phosphatidylinositol 3 (PI3) kinase. When used at a concentration of 50 μM, it specifically abolished PI3 kinase activity (IC50=0.43 μg/ml; 1.40 μM) but did not inhibit other lipid and protein kinases such as PI4 kinase, PKC, MAP kinase or c-Src.

Experimental Design and Results Summary

Application

Western blotting following in vitro culture

Starting Material

Mouse immune cells

Protocol Overview

Pretreat cells with inhibitor at 1 hr prior to signal transduction experiment

Tips

Titrate different concentrations for best result

Results Summary

10uM works well in inhibiting insulin-induced pAkt signaling

DOI or PMID #

N/A

Additional Notes

N/A

Related Categories

Image Gallery

Summary

The Good

Works as expected

The Bad

N/A

The Bottom Line

Recommend for use to inhibit PI3K in cultured cells in vitro

Join the discussion